Screening cancer epitopes, particularly neoepitope antigens, has become increasingly important in drug discovery and immunotherapy in recent years. Creative Biolabs provides various T and B cell-based epitope analysis assays, including T cell-based 3H-thymidine assay, to analyze cancer pathogenic epitopes.
Cancer antigen epitopes are specific molecules that target T and B cell receptors and induce complex immune responses. Cancer epitopes are typically derived from somatic mutations that cause tumorigenesis and may progress to various diseases and cancer. T cell proliferation analysis is a reliable and reproducible method to determine the presence and frequency of epitope-specific T cells. The use of a 3H-thymidine incorporation assay to investigate T cell proliferative response is a validated tool to screen and test cancer pathogenic epitopes.
Fig.1 Schematic representation of 3H-thymidine assay.1
Creative Biolabs has developed a robust T cell assay platform to provide reliable 3H-thymidine assay to our clients worldwide. Based on your objectives, our experts will design scientific experiments and conduct high-quality studies to support your research.
Fig.2 The workflow of T cell-based 3H-thymidine assay. (Creative Biolabs)
T cell proliferation detects antigen-responsive T cells generated from in vitro and in vivo models.
In Vitro Model
In Vivo Model
The data interpretation is a necessary aspect of the assay. We have established standardized protocols to identify a cut-off value to distinguish positive results from negative ones.
Fig.3 Cell proliferation to human thyroglobulin peptides.2
Creative Biolabs is a professional provider of bioassays. Our years of program development services provided us with a wealth of experience, allowing us to collaborate closely with our clients to provide T cell assays, including design and operation. Our assay provides clients with consistent and reproducible results. Please feel free to contact us us to get more information.
For Research Use Only | Not For Clinical Use